Soichiro Torigoe

1.2k total citations
19 papers, 993 citations indexed

About

Soichiro Torigoe is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Soichiro Torigoe has authored 19 papers receiving a total of 993 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cancer Research, 9 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Soichiro Torigoe's work include Cancer-related Molecular Pathways (5 papers), Cancer Genomics and Diagnostics (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Soichiro Torigoe is often cited by papers focused on Cancer-related Molecular Pathways (5 papers), Cancer Genomics and Diagnostics (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Soichiro Torigoe collaborates with scholars based in Japan and United States. Soichiro Torigoe's co-authors include Taro Shuin, Masahiko Hosaka, Keiichi Kondo, Y. Kubota, Farida Latif, Berton Zbar, Yoji Nagashima, Takeshi Kishida, Hiroshi Kitamura and Yoshinobu Kubota and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and British Journal of Cancer.

In The Last Decade

Soichiro Torigoe

19 papers receiving 963 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Soichiro Torigoe Japan 13 648 489 343 272 165 19 993
Kuniharu Miyajima Japan 17 969 1.5× 263 0.5× 328 1.0× 335 1.2× 166 1.0× 37 1.5k
Yozo Kawano Japan 19 657 1.0× 362 0.7× 331 1.0× 435 1.6× 97 0.6× 28 1.2k
Ubaradka G. Sathyanarayana United States 17 1.1k 1.6× 323 0.7× 498 1.5× 276 1.0× 102 0.6× 22 1.4k
Colm Hennessy United Kingdom 13 542 0.8× 232 0.5× 209 0.6× 524 1.9× 91 0.6× 19 1.1k
Ivan Ischenko Germany 19 621 1.0× 269 0.6× 140 0.4× 507 1.9× 168 1.0× 22 1.2k
Anna Dowe United Kingdom 13 537 0.8× 264 0.5× 335 1.0× 245 0.9× 56 0.3× 15 951
Elio Geido Italy 19 294 0.5× 355 0.7× 130 0.4× 413 1.5× 126 0.8× 47 900
Kimberly W. McCrudden United States 13 574 0.9× 296 0.6× 130 0.4× 242 0.9× 69 0.4× 17 827
Heidi Bissig Switzerland 8 477 0.7× 188 0.4× 165 0.5× 386 1.4× 93 0.6× 8 824
Takuji Mori Japan 16 513 0.8× 254 0.5× 181 0.5× 515 1.9× 119 0.7× 31 1.0k

Countries citing papers authored by Soichiro Torigoe

Since Specialization
Citations

This map shows the geographic impact of Soichiro Torigoe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Soichiro Torigoe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Soichiro Torigoe more than expected).

Fields of papers citing papers by Soichiro Torigoe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Soichiro Torigoe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Soichiro Torigoe. The network helps show where Soichiro Torigoe may publish in the future.

Co-authorship network of co-authors of Soichiro Torigoe

This figure shows the co-authorship network connecting the top 25 collaborators of Soichiro Torigoe. A scholar is included among the top collaborators of Soichiro Torigoe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Soichiro Torigoe. Soichiro Torigoe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Murata, Shogo, Makoto Adachi, Mitomu Kioi, et al.. (2011). Etodolac improves 5-FU sensitivity of head and neck cancer cells through inhibition of thymidylate synthase.. PubMed. 31(9). 2893–8. 14 indexed citations
2.
Kojima, Shinsuke, Bin Zhou, Satoshi Teramukai, et al.. (2007). Cancer screening of healthy volunteers using whole-body 18F-FDG-PET scans: The Nishidai clinic study. European Journal of Cancer. 43(12). 1842–1848. 40 indexed citations
3.
Kojima, Shinsuke, N Kosaka, Yukinori Matsuo, et al.. (2004). Cancer screening using whole-body 18FDG-PET scan in healthy voluntary subjects. Journal of Clinical Oncology. 22(14_suppl). 6072–6072. 1 indexed citations
4.
Kojima, Shinsuke, Akio Hara, N Kosaka, et al.. (2004). Cancer screening using whole-body 18FDG-PET scan in healthy voluntary subjects. Journal of Clinical Oncology. 22(14_suppl). 6072–6072. 1 indexed citations
5.
Omura, Motoko, Soichiro Torigoe, Hiroaki Kurihara, Sho Matsubara, & Nobuo Kubota. (1998). Comparison between Fractionated High Dose Rate Irradiation and Continuous Low Dose Rate Irradiation in Spheroids. Acta Oncologica. 37(7-8). 681–686. 9 indexed citations
6.
Kurihara, Hiroaki, et al.. (1998). DNA Fragmentation Induced by a Cytoplasmic Extract from Irradiated Cells. Radiation Research. 150(3). 269–269. 6 indexed citations
7.
Omura, Motoko, Soichiro Torigoe, & Nobuo Kubota. (1997). SN-38, a metabolite of the camptothecin derivative CPT-11, potentiates the cytotoxic effect of radiation in human colon adenocarcinoma cells grown as spheroids. Radiotherapy and Oncology. 43(2). 197–201. 40 indexed citations
8.
Matsubara, Sho, Motoko Omura, Hideyuki Kurihara, et al.. (1997). The Effect of Iodine-Based Contrast Agents on the Levels of Radiation-Induced Chromosomal Aberrations. Radiation Research. 147(2). 263–263. 10 indexed citations
9.
Kanno, Hiroshi, Taro Shuin, Keiichi Kondo, et al.. (1996). Molecular Genetic Diagnosis of von Hippel‐Lindau Disease: Analysis of Five Japanese Families. Japanese Journal of Cancer Research. 87(5). 423–428. 13 indexed citations
10.
Miyamoto, Hiroshi, Taro Shuin, Soichiro Torigoe, Yuzuru Iwasaki, & Y. Kubota. (1995). Retinoblastoma gene mutations in primary human bladder cancer. British Journal of Cancer. 71(4). 831–835. 62 indexed citations
11.
Miyamoto, Hiroshi, et al.. (1995). Expression of transforming growth factor-beta 1 in human bladder cancer. Cancer. 75(10). 2565–2570. 39 indexed citations
12.
Kubota, Yoshinobu, Taro Shuin, Hiroji Uemura, et al.. (1995). Tumor suppressor gene P53 mutations in human prostate cancer. The Prostate. 27(1). 18–24. 46 indexed citations
13.
Kubota, Yoshinobu, et al.. (1995). Polymorphisms in the human DNA polymerase ? gene. Human Genetics. 95(4). 389–90. 18 indexed citations
14.
Shuin, Taro, Soichiro Torigoe, Y. Kubota, et al.. (1995). Retinoblastoma gene mutation in primary human renal cell carcinoma.. PubMed. 7(2). 63–6. 3 indexed citations
15.
Kanno, Hiroshi, Keiichi Kondo, Sadayoshi Ito, et al.. (1994). Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas.. PubMed. 54(18). 4845–7. 175 indexed citations
16.
Shuin, Taro, Keiichi Kondo, Soichiro Torigoe, et al.. (1994). Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas.. PubMed. 54(11). 2852–5. 395 indexed citations
17.
Shuin, Taro, et al.. (1994). DNA polymerase beta gene mutation in human prostate cancer.. PubMed. 54(11). 2827–9. 67 indexed citations
18.
Miyamoto, Hiroshi, Yoshinobu Kubota, Taro Shuin, et al.. (1993). Analyses of p53 gene mutations in primary human bladder cancer.. PubMed. 5(6-7). 245–9. 38 indexed citations
19.
Torigoe, Soichiro, et al.. (1992). p53 gene mutation in primary human renal cell carcinoma.. PubMed. 4(11-12). 467–72. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026